Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment

Go back to Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
Uni-Pixel, Inc. (NASDAQ: NXL) Delayed: 0.43 -0.04 (8.51%)
Previous Close $0.47    52 Week High $0.68 
Open $0.47    52 Week Low $0.62 
Day High $0.47    P/E N/A 
Day Low $0.43    EPS $0.00 
Volume 89,904